AbbVie | ABBV - Capitaux Propres Et Réserves

Prix De L'Action
221.92
Variation Quotidienne
0.47 0.21%
Mensuellement
-2.97%
Annuel
3.77%
Q1 Prévisions
213.05




Capitaux Propres Et Réserves Changement Date
AbbVie USD -3.27B 628M 2025-12
Abbott USD 52.13B 1.3B 2025-12
ALKERMES USD 1.82B 85.86M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
J&J USD 78.47B 0 2025-09
Medtronic USD 48.86B 964M 2025-09
Merck USD 51.85B 2.79B 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 44.75B 2.7B 2025-09
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
UCB EUR 10.03B 1.08B 2024-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Zoetis USD 3.33B 2.07B 2025-12